Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.80 +41.65 (+0.51%) Bitcoin USD
61,703.62 +3,125.54 (+5.34%) CMC Crypto 200
1,326.56 +49.58 (+3.88%)
STRATA Skin Sciences, Inc. (SSKN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
As of 10:30AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 14.02M |
| Enterprise value | 22.87M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.42 |
| Price/book (mrq) | 1.11 |
| Enterprise value/revenue | 0.69 |
| Enterprise value/EBITDA | -6.77 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.60 |
| 52-week change 3 | -60.78% |
| S&P500 52-week change 3 | 22.43% |
| 52-week high 3 | 1.1000 |
| 52-week low 3 | 0.2600 |
| 50-day moving average 3 | 0.4938 |
| 200-day moving average 3 | 0.5706 |
Share statistics
| Avg vol (3-month) 3 | 27.42k |
| Avg vol (10-day) 3 | 26.04k |
| Shares outstanding 5 | 35.06M |
| Implied shares outstanding 6 | 35.06M |
| Float 8 | 11.94M |
| % held by insiders 1 | 6.04% |
| % held by institutions 1 | 66.97% |
| Shares short (15 Apr 2024) 4 | 157.23k |
| Short ratio (15 Apr 2024) 4 | 4.14 |
| Short % of float (15 Apr 2024) 4 | 0.84% |
| Short % of shares outstanding (15 Apr 2024) 4 | 0.45% |
| Shares short (prior month 15 Mar 2024) 4 | 217.93k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 07 Apr 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 07 Apr 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -32.47% |
| Operating margin (ttm) | -13.32% |
Management effectiveness
| Return on assets (ttm) | -8.38% |
| Return on equity (ttm) | -62.75% |
Income statement
| Revenue (ttm) | 33.36M |
| Revenue per share (ttm) | 0.95 |
| Quarterly revenue growth (yoy) | -18.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -767k |
| Net income avi to common (ttm) | -10.83M |
| Diluted EPS (ttm) | -0.3100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.78M |
| Total cash per share (mrq) | 0.19 |
| Total debt (mrq) | 15.63M |
| Total debt/equity (mrq) | 123.21% |
| Current ratio (mrq) | 1.28 |
| Book value per share (mrq) | 0.36 |
Cash flow statement
| Operating cash flow (ttm) | -519k |
| Levered free cash flow (ttm) | -3.04M |
© 2024 Yahoo. All rights reserved.